Earnings in pharmaceutical sector seen positive

Published: 2006-11-20 07:00:00

Updated: 2006-11-20 07:00:00

Amid depressed OTC demand and a slumping economy, sales by pharmaceutical firms have been gradually gaining momentum from this year, thanks to their aggressive marketing in flagship products.

According to Yakup Shinmoon, the combined sales of 26 firms listed on the main stock bourse whose fisc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK